Stockreport

Merck in talks to buy cancer drugmaker Revolution Medicines [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn, [Read more]